The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial).
 
Jens Hoeppner
Travel, Accommodations, Expenses - Intuitive Surgical
 
Thomas Brunner
Honoraria - AstraZeneca; Daiichi Sankyo; Merck
 
Florian Lordick
Honoraria - Art Tempi; Astellas Pharma; AstraZeneca; BioNTech; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Falk Foundation; Incyte; Lilly; Medscape; Medupdate; Merck KGaA; Merck Sharp & Dohme; Novartis; Roche; SERVIER; Streamedup!
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Bristol-Myers Squibb; Daichi Sankyo; Merck Sharp & Dohme; PAGE
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly
 
Claudia Schmoor
Consulting or Advisory Role - Novartis; Roche Pharma AG
Research Funding - Boehringer Ingelheim
 
Birte Kulemann
No Relationships to Disclose
 
Ulf Peter Neumann
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Falk Pharma; Merck; Novartis; Roche
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; Falk Pharma; Merck; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Chiasi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Falk Pharma; Merck
 
Gunnar Folprecht
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daichi; Exact Sciences; GlaxoSmithKline; Incyte; Janssen; Merck KGaA; Merck Sharp & Dohme; Pierre Fabre; Pierre Fabre; Roche/Genentech; SERVIER; Takeda
Research Funding - Merck KGaA (Inst)
 
Tobias Keck
Speakers' Bureau - AstraZeneca
 
Frank Benedix
Travel, Accommodations, Expenses - W. L. Gore & Associates
 
Maximilan Schmeding
No Relationships to Disclose
 
Ernst Reitsamer
No Relationships to Disclose
 
Christiane J. Bruns
Honoraria - AstraZeneca; Intuitive Surgical; Medtronic; Medupdate
Consulting or Advisory Role - Intuitive Surgical; Medtronic
Research Funding - Intuitive Surgical; Medtronic; Stryker
Travel, Accommodations, Expenses - Intuitive Surgical; Medtronic; Stryker
 
Johan F. Lock
No Relationships to Disclose
 
Benedikt Reichert
No Relationships to Disclose
 
Michael Ghadimi
Travel, Accommodations, Expenses - JJ Innovative Medicine; Olympus
 
Kai Wille
No Relationships to Disclose
 
Ines Gockel
Honoraria - FALK Foundation; Johnson & Johnson/Janssen; Onkowissen
 
Jakob R. Izbicki
No Relationships to Disclose
 
Stefan Utzolino
No Relationships to Disclose
 
Peter Philipp Grimminger
Honoraria - AstraZeneca; Intuitive Surgical
Consulting or Advisory Role - AstraZeneca; Intuitive Surgical; Medtronic
Research Funding - Intuitive Grant